Intravitreal Bevacizumab versus Laser Therapy in Retinopathy of Prematurity: Analyzing Retreatment Rates, Timing, and Risk Predictors
Posted innews Ophthalmology Pediatrics

Intravitreal Bevacizumab versus Laser Therapy in Retinopathy of Prematurity: Analyzing Retreatment Rates, Timing, and Risk Predictors

This study compares retreatment rates and timing in retinopathy of prematurity among infants treated with intravitreal bevacizumab versus laser therapy, highlighting lower early retreatment rates and delayed intervention in the bevacizumab group, especially in high-risk premature infants.
Unveiling Postpancreatectomy Hemorrhage: Bleeding Sources, Cryptogenic Events, and Predictors of Severity from a Large Cohort Analysis
Posted inGastroenterology General Surgery news

Unveiling Postpancreatectomy Hemorrhage: Bleeding Sources, Cryptogenic Events, and Predictors of Severity from a Large Cohort Analysis

This study of 1,722 pancreaticoduodenectomies identifies key bleeding sources and predictors for severe postpancreatectomy hemorrhage, highlighting the roles of bile leak and infection in patients with pancreatic fistula and redefining cryptogenic hemorrhage as a lower-risk subgroup.
Enhancing Precision in Minimally Invasive Liver Resection for Colorectal Metastases Using Indocyanine Green Fluorescence: Insights from the SICE Liver ICG Study
Posted inGeneral Surgery news Oncology

Enhancing Precision in Minimally Invasive Liver Resection for Colorectal Metastases Using Indocyanine Green Fluorescence: Insights from the SICE Liver ICG Study

The SICE Liver ICG study demonstrated that indocyanine green fluorescence imaging significantly improves detection and margin assessment during minimally invasive, parenchymal-sparing liver resections for colorectal metastases, supporting more precise surgery and better oncologic outcomes.
Farletuzumab Ecteribulin: Optimizing Dosing to Mitigate Lung Toxicity While Targeting Folate Receptor Alpha in Advanced Cancers
Posted innews OB/GYN & Women's Health Oncology

Farletuzumab Ecteribulin: Optimizing Dosing to Mitigate Lung Toxicity While Targeting Folate Receptor Alpha in Advanced Cancers

This phase 1/2 study evaluates farletuzumab ecteribulin, a folate receptor alpha-targeting ADC, showing that fractionated dosing reduces interstitial lung disease risk and demonstrates preliminary antitumor activity in advanced ovarian, endometrial, triple-negative breast, and lung cancers.
Racial and Ethnic Disparities in Treatment Initiation and Survival Among Patients With Endometrial Cancer: Socioeconomic Modifiers and Clinical Implications
Posted inClinical Updates news OB/GYN & Women's Health Oncology

Racial and Ethnic Disparities in Treatment Initiation and Survival Among Patients With Endometrial Cancer: Socioeconomic Modifiers and Clinical Implications

This review synthesizes recent evidence demonstrating persistent racial and ethnic disparities in treatment initiation and survival among patients with advanced endometrial cancer, highlighting the critical influence of socioeconomic status and social determinants on outcomes.